Caloric restriction mimetics: towards a molecular definition
Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity....
Gespeichert in:
Veröffentlicht in: | Nature reviews. Drug discovery 2014-10, Vol.13 (10), p.727-740 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 740 |
---|---|
container_issue | 10 |
container_start_page | 727 |
container_title | Nature reviews. Drug discovery |
container_volume | 13 |
creator | Madeo, Frank Pietrocola, Federico Eisenberg, Tobias Kroemer, Guido |
description | Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs.
Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents. |
doi_str_mv | 10.1038/nrd4391 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1567051439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A385803035</galeid><sourcerecordid>A385803035</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</originalsourceid><addsrcrecordid>eNptkUtLAzEUhYMoVqv4D2TAhW5a885U3EjxBQU3uh4yyZ2SMjOpyQzivzfF2mqRLG5Ivns49x6EzggeE8zy6zZYziZkDx0RrviIqJzvb-5KDtBxjAuMiSSKHqIBFZRQiekRup3q2gdnsgCxS7Vzvs0a10DnTLzJOv-hg42Zzhpfg-lrHTILlWvdCjxBB5WuI5yu6xC9Pdy_Tp9Gs5fH5-ndbGQEF11yMMG21LnAElReYqpACk4rSS0omyvQqqo4YRNWEp7UQdiJAqLAUKwoL9kQXX3rLoN_75PRonHRQF3rFnwfCyKkwoKkDST0Ygdd-D60yd2KkpJRRfGWmusaCtdWvgvarESLO5aLHDPMRKLG_1DpWGic8W3aQ3r_03D53WCCjzFAVSyDa3T4LAguVjkV65wSeb622ZcN2A33E8x25Ji-2jmEX3PsaH0BhaKYDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566632720</pqid></control><display><type>article</type><title>Caloric restriction mimetics: towards a molecular definition</title><source>MEDLINE</source><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Madeo, Frank ; Pietrocola, Federico ; Eisenberg, Tobias ; Kroemer, Guido</creator><creatorcontrib>Madeo, Frank ; Pietrocola, Federico ; Eisenberg, Tobias ; Kroemer, Guido</creatorcontrib><description>Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs.
Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.</description><identifier>ISSN: 1474-1776</identifier><identifier>EISSN: 1474-1784</identifier><identifier>DOI: 10.1038/nrd4391</identifier><identifier>PMID: 25212602</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/154/555 ; 631/337/458/1275 ; 631/80/39 ; 692/699/2743/2037 ; Acetyl Coenzyme A - metabolism ; Acetylation - drug effects ; Acetyltransferases - antagonists & inhibitors ; Animals ; Autophagy - drug effects ; Biomedicine ; Biotechnology ; Caloric Restriction - methods ; Cancer Research ; Drug Design ; Drug therapy ; Humans ; Innovations ; Medicinal Chemistry ; Metabolic diseases ; Molecular Medicine ; Molecular targeted therapy ; opinion-2 ; Pharmacology, Experimental ; Pharmacology/Toxicology ; Weight reducing preparations</subject><ispartof>Nature reviews. Drug discovery, 2014-10, Vol.13 (10), p.727-740</ispartof><rights>Springer Nature Limited 2014</rights><rights>COPYRIGHT 2014 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Oct 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</citedby><cites>FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25212602$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Madeo, Frank</creatorcontrib><creatorcontrib>Pietrocola, Federico</creatorcontrib><creatorcontrib>Eisenberg, Tobias</creatorcontrib><creatorcontrib>Kroemer, Guido</creatorcontrib><title>Caloric restriction mimetics: towards a molecular definition</title><title>Nature reviews. Drug discovery</title><addtitle>Nat Rev Drug Discov</addtitle><addtitle>Nat Rev Drug Discov</addtitle><description>Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs.
Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.</description><subject>631/154/555</subject><subject>631/337/458/1275</subject><subject>631/80/39</subject><subject>692/699/2743/2037</subject><subject>Acetyl Coenzyme A - metabolism</subject><subject>Acetylation - drug effects</subject><subject>Acetyltransferases - antagonists & inhibitors</subject><subject>Animals</subject><subject>Autophagy - drug effects</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Caloric Restriction - methods</subject><subject>Cancer Research</subject><subject>Drug Design</subject><subject>Drug therapy</subject><subject>Humans</subject><subject>Innovations</subject><subject>Medicinal Chemistry</subject><subject>Metabolic diseases</subject><subject>Molecular Medicine</subject><subject>Molecular targeted therapy</subject><subject>opinion-2</subject><subject>Pharmacology, Experimental</subject><subject>Pharmacology/Toxicology</subject><subject>Weight reducing preparations</subject><issn>1474-1776</issn><issn>1474-1784</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkUtLAzEUhYMoVqv4D2TAhW5a885U3EjxBQU3uh4yyZ2SMjOpyQzivzfF2mqRLG5Ivns49x6EzggeE8zy6zZYziZkDx0RrviIqJzvb-5KDtBxjAuMiSSKHqIBFZRQiekRup3q2gdnsgCxS7Vzvs0a10DnTLzJOv-hg42Zzhpfg-lrHTILlWvdCjxBB5WuI5yu6xC9Pdy_Tp9Gs5fH5-ndbGQEF11yMMG21LnAElReYqpACk4rSS0omyvQqqo4YRNWEp7UQdiJAqLAUKwoL9kQXX3rLoN_75PRonHRQF3rFnwfCyKkwoKkDST0Ygdd-D60yd2KkpJRRfGWmusaCtdWvgvarESLO5aLHDPMRKLG_1DpWGic8W3aQ3r_03D53WCCjzFAVSyDa3T4LAguVjkV65wSeb622ZcN2A33E8x25Ji-2jmEX3PsaH0BhaKYDA</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Madeo, Frank</creator><creator>Pietrocola, Federico</creator><creator>Eisenberg, Tobias</creator><creator>Kroemer, Guido</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20141001</creationdate><title>Caloric restriction mimetics: towards a molecular definition</title><author>Madeo, Frank ; Pietrocola, Federico ; Eisenberg, Tobias ; Kroemer, Guido</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>631/154/555</topic><topic>631/337/458/1275</topic><topic>631/80/39</topic><topic>692/699/2743/2037</topic><topic>Acetyl Coenzyme A - metabolism</topic><topic>Acetylation - drug effects</topic><topic>Acetyltransferases - antagonists & inhibitors</topic><topic>Animals</topic><topic>Autophagy - drug effects</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Caloric Restriction - methods</topic><topic>Cancer Research</topic><topic>Drug Design</topic><topic>Drug therapy</topic><topic>Humans</topic><topic>Innovations</topic><topic>Medicinal Chemistry</topic><topic>Metabolic diseases</topic><topic>Molecular Medicine</topic><topic>Molecular targeted therapy</topic><topic>opinion-2</topic><topic>Pharmacology, Experimental</topic><topic>Pharmacology/Toxicology</topic><topic>Weight reducing preparations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madeo, Frank</creatorcontrib><creatorcontrib>Pietrocola, Federico</creatorcontrib><creatorcontrib>Eisenberg, Tobias</creatorcontrib><creatorcontrib>Kroemer, Guido</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madeo, Frank</au><au>Pietrocola, Federico</au><au>Eisenberg, Tobias</au><au>Kroemer, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caloric restriction mimetics: towards a molecular definition</atitle><jtitle>Nature reviews. Drug discovery</jtitle><stitle>Nat Rev Drug Discov</stitle><addtitle>Nat Rev Drug Discov</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>13</volume><issue>10</issue><spage>727</spage><epage>740</epage><pages>727-740</pages><issn>1474-1776</issn><eissn>1474-1784</eissn><abstract>Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs.
Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>25212602</pmid><doi>10.1038/nrd4391</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1474-1776 |
ispartof | Nature reviews. Drug discovery, 2014-10, Vol.13 (10), p.727-740 |
issn | 1474-1776 1474-1784 |
language | eng |
recordid | cdi_proquest_miscellaneous_1567051439 |
source | MEDLINE; Nature; Alma/SFX Local Collection |
subjects | 631/154/555 631/337/458/1275 631/80/39 692/699/2743/2037 Acetyl Coenzyme A - metabolism Acetylation - drug effects Acetyltransferases - antagonists & inhibitors Animals Autophagy - drug effects Biomedicine Biotechnology Caloric Restriction - methods Cancer Research Drug Design Drug therapy Humans Innovations Medicinal Chemistry Metabolic diseases Molecular Medicine Molecular targeted therapy opinion-2 Pharmacology, Experimental Pharmacology/Toxicology Weight reducing preparations |
title | Caloric restriction mimetics: towards a molecular definition |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A24%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caloric%20restriction%20mimetics:%20towards%20a%20molecular%20definition&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Madeo,%20Frank&rft.date=2014-10-01&rft.volume=13&rft.issue=10&rft.spage=727&rft.epage=740&rft.pages=727-740&rft.issn=1474-1776&rft.eissn=1474-1784&rft_id=info:doi/10.1038/nrd4391&rft_dat=%3Cgale_proqu%3EA385803035%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1566632720&rft_id=info:pmid/25212602&rft_galeid=A385803035&rfr_iscdi=true |